课题基金 / 基金详情

项目摘要

项目成果

Juan Marugan的其他基金

相似基金

相关文献

中文摘要
翻译
新型小分子RXFP3激动剂和拮抗剂将为阐明松弛素-3的功能及其对RXFP3受体的作用提供有价值的工具。在此期间,项目团队成功开发了一种1536孔的高通量分析方法,用于筛选能够刺激或拮抗RXFP3受体的小分子。研究人员筛选了超过50,000个小分子,以确定其对cAMP水平的影响,并开发了几种反筛剂来表征筛选结果,并帮助识别靶RXFP3调节剂。还进行了虚拟筛选,以确定测试候选人的优先顺序。
英文摘要
Novel small molecule RXFP3 agonists and antagonists will be valuable tools to elucidate the functions of relaxin-3 and its actions at RXFP3 receptors. During this period, the project team successfully developed a 1536-well high-throughput assay to screen for small molecules that agonize or antagonize the RXFP3 receptor. More than 50,000 small molecules were screened for effects on cAMP levels, and several counterscreens have been developed to characterize screening hits and help identify on-target RXFP3 modulators. Virtual screening was also performed to prioritize candidates for testing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecule agonists of the relaxin 1 receptor
Identification of Small Molecule that act on gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome
Kinetic High Throughput Screening for Agonists and Inhibitors of the TRPML1 Ion channel
HTS Assay for Identification of Compounds that Reduce PNC Prevalence
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: